nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CA1—esophageal cancer	0.368	0.569	CbGaD
Zonisamide—CA2—esophageal cancer	0.279	0.431	CbGaD
Zonisamide—AOX1—Methotrexate—esophageal cancer	0.0116	1	CbGbCtD
Zonisamide—CA3—pericardium—esophageal cancer	0.00892	0.118	CbGeAlD
Zonisamide—CA6—exocrine gland—esophageal cancer	0.00345	0.0455	CbGeAlD
Zonisamide—SCN4B—bronchus—esophageal cancer	0.00266	0.0352	CbGeAlD
Zonisamide—SCN4B—trachea—esophageal cancer	0.00239	0.0316	CbGeAlD
Zonisamide—CA11—bronchus—esophageal cancer	0.00229	0.0303	CbGeAlD
Zonisamide—SCN1B—lung—esophageal cancer	0.00219	0.0289	CbGeAlD
Zonisamide—CA13—digestive system—esophageal cancer	0.00211	0.0278	CbGeAlD
Zonisamide—CA11—trachea—esophageal cancer	0.00206	0.0272	CbGeAlD
Zonisamide—SCN3B—lung—esophageal cancer	0.00202	0.0267	CbGeAlD
Zonisamide—CA13—lung—esophageal cancer	0.00176	0.0233	CbGeAlD
Zonisamide—SCN4B—lung—esophageal cancer	0.00172	0.0227	CbGeAlD
Zonisamide—SCN1B—lymph node—esophageal cancer	0.0015	0.0198	CbGeAlD
Zonisamide—CA11—lung—esophageal cancer	0.00148	0.0195	CbGeAlD
Zonisamide—SCN11A—digestive system—esophageal cancer	0.00144	0.0191	CbGeAlD
Zonisamide—CA8—lymph node—esophageal cancer	0.00141	0.0186	CbGeAlD
Zonisamide—SCN3B—lymph node—esophageal cancer	0.00138	0.0182	CbGeAlD
Zonisamide—CACNA1G—digestive system—esophageal cancer	0.00138	0.0182	CbGeAlD
Zonisamide—CA7—trachea—esophageal cancer	0.00137	0.0181	CbGeAlD
Zonisamide—CA13—lymph node—esophageal cancer	0.0012	0.0159	CbGeAlD
Zonisamide—CA2—exocrine gland—esophageal cancer	0.00119	0.0157	CbGeAlD
Zonisamide—CA7—digestive system—esophageal cancer	0.00118	0.0155	CbGeAlD
Zonisamide—SCN4B—lymph node—esophageal cancer	0.00117	0.0155	CbGeAlD
Zonisamide—CACNA1I—lymph node—esophageal cancer	0.00115	0.0151	CbGeAlD
Zonisamide—CACNA1H—smooth muscle tissue—esophageal cancer	0.00114	0.0151	CbGeAlD
Zonisamide—CA9—digestive system—esophageal cancer	0.00103	0.0137	CbGeAlD
Zonisamide—CA11—lymph node—esophageal cancer	0.00101	0.0134	CbGeAlD
Zonisamide—CA4—neck—esophageal cancer	0.000915	0.0121	CbGeAlD
Zonisamide—CA3—lung—esophageal cancer	0.000902	0.0119	CbGeAlD
Zonisamide—CA12—trachea—esophageal cancer	0.000889	0.0117	CbGeAlD
Zonisamide—AOX1—bronchus—esophageal cancer	0.000826	0.0109	CbGeAlD
Zonisamide—MAOA—neck—esophageal cancer	0.00081	0.0107	CbGeAlD
Zonisamide—SCN9A—lung—esophageal cancer	0.000803	0.0106	CbGeAlD
Zonisamide—CA12—digestive system—esophageal cancer	0.000765	0.0101	CbGeAlD
Zonisamide—CA2—neck—esophageal cancer	0.000759	0.01	CbGeAlD
Zonisamide—AOX1—trachea—esophageal cancer	0.000742	0.0098	CbGeAlD
Zonisamide—SCN1A—lung—esophageal cancer	0.00069	0.00912	CbGeAlD
Zonisamide—SCN5A—digestive system—esophageal cancer	0.000665	0.00878	CbGeAlD
Zonisamide—CA12—lung—esophageal cancer	0.000639	0.00844	CbGeAlD
Zonisamide—AOX1—digestive system—esophageal cancer	0.000638	0.00843	CbGeAlD
Zonisamide—MAOB—bronchus—esophageal cancer	0.000637	0.00841	CbGeAlD
Zonisamide—CA3—lymph node—esophageal cancer	0.000617	0.00815	CbGeAlD
Zonisamide—CA1—digestive system—esophageal cancer	0.000606	0.008	CbGeAlD
Zonisamide—CA5B—lung—esophageal cancer	0.000573	0.00757	CbGeAlD
Zonisamide—SCN3A—lung—esophageal cancer	0.000557	0.00735	CbGeAlD
Zonisamide—CA4—trachea—esophageal cancer	0.000551	0.00727	CbGeAlD
Zonisamide—SCN9A—lymph node—esophageal cancer	0.000549	0.00725	CbGeAlD
Zonisamide—MAOA—bronchus—esophageal cancer	0.000543	0.00717	CbGeAlD
Zonisamide—AOX1—lung—esophageal cancer	0.000533	0.00704	CbGeAlD
Zonisamide—CA2—epithelium—esophageal cancer	0.000516	0.00682	CbGeAlD
Zonisamide—CACNA1H—lymph node—esophageal cancer	0.000514	0.00679	CbGeAlD
Zonisamide—CA2—bronchus—esophageal cancer	0.000508	0.00671	CbGeAlD
Zonisamide—CA1—lung—esophageal cancer	0.000506	0.00668	CbGeAlD
Zonisamide—CA2—smooth muscle tissue—esophageal cancer	0.000497	0.00657	CbGeAlD
Zonisamide—MAOB—digestive system—esophageal cancer	0.000492	0.00649	CbGeAlD
Zonisamide—MAOA—trachea—esophageal cancer	0.000488	0.00644	CbGeAlD
Zonisamide—CA4—digestive system—esophageal cancer	0.000474	0.00625	CbGeAlD
Zonisamide—CA2—trachea—esophageal cancer	0.000456	0.00603	CbGeAlD
Zonisamide—CYP2C19—digestive system—esophageal cancer	0.000429	0.00566	CbGeAlD
Zonisamide—MAOA—digestive system—esophageal cancer	0.00042	0.00554	CbGeAlD
Zonisamide—MAOB—lung—esophageal cancer	0.000411	0.00542	CbGeAlD
Zonisamide—CA4—lung—esophageal cancer	0.000396	0.00522	CbGeAlD
Zonisamide—CA2—digestive system—esophageal cancer	0.000393	0.00519	CbGeAlD
Zonisamide—CA5B—lymph node—esophageal cancer	0.000392	0.00518	CbGeAlD
Zonisamide—SCN3A—lymph node—esophageal cancer	0.000381	0.00503	CbGeAlD
Zonisamide—AOX1—lymph node—esophageal cancer	0.000365	0.00481	CbGeAlD
Zonisamide—MAOA—lung—esophageal cancer	0.00035	0.00463	CbGeAlD
Zonisamide—CA1—lymph node—esophageal cancer	0.000346	0.00457	CbGeAlD
Zonisamide—CA2—lung—esophageal cancer	0.000328	0.00433	CbGeAlD
Zonisamide—Renal failure—Cisplatin—esophageal cancer	0.00032	0.00349	CcSEcCtD
Zonisamide—Pulmonary embolism—Methotrexate—esophageal cancer	0.00032	0.00348	CcSEcCtD
Zonisamide—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00032	0.00348	CcSEcCtD
Zonisamide—Cardiac failure—Capecitabine—esophageal cancer	0.00032	0.00348	CcSEcCtD
Zonisamide—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000318	0.00346	CcSEcCtD
Zonisamide—Stomatitis—Cisplatin—esophageal cancer	0.000318	0.00346	CcSEcCtD
Zonisamide—Conjunctivitis—Cisplatin—esophageal cancer	0.000317	0.00345	CcSEcCtD
Zonisamide—Hyponatraemia—Capecitabine—esophageal cancer	0.000313	0.00341	CcSEcCtD
Zonisamide—Melaena—Methotrexate—esophageal cancer	0.000312	0.0034	CcSEcCtD
Zonisamide—Osteoarthritis—Capecitabine—esophageal cancer	0.000312	0.00339	CcSEcCtD
Zonisamide—Diplopia—Capecitabine—esophageal cancer	0.000312	0.00339	CcSEcCtD
Zonisamide—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000309	0.00337	CcSEcCtD
Zonisamide—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000309	0.00336	CcSEcCtD
Zonisamide—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000308	0.00335	CcSEcCtD
Zonisamide—Face oedema—Capecitabine—esophageal cancer	0.000301	0.00328	CcSEcCtD
Zonisamide—Aplastic anaemia—Methotrexate—esophageal cancer	0.0003	0.00327	CcSEcCtD
Zonisamide—Bradycardia—Cisplatin—esophageal cancer	0.000298	0.00324	CcSEcCtD
Zonisamide—Irritability—Capecitabine—esophageal cancer	0.000298	0.00324	CcSEcCtD
Zonisamide—Urinary retention—Capecitabine—esophageal cancer	0.000296	0.00323	CcSEcCtD
Zonisamide—Mood swings—Capecitabine—esophageal cancer	0.000295	0.00321	CcSEcCtD
Zonisamide—Ataxia—Capecitabine—esophageal cancer	0.000293	0.00319	CcSEcCtD
Zonisamide—Coma—Methotrexate—esophageal cancer	0.000292	0.00318	CcSEcCtD
Zonisamide—Blood creatinine increased—Capecitabine—esophageal cancer	0.000292	0.00318	CcSEcCtD
Zonisamide—Dehydration—Capecitabine—esophageal cancer	0.00029	0.00316	CcSEcCtD
Zonisamide—Bladder pain—Methotrexate—esophageal cancer	0.000289	0.00315	CcSEcCtD
Zonisamide—Mouth ulceration—Methotrexate—esophageal cancer	0.000289	0.00315	CcSEcCtD
Zonisamide—Ecchymosis—Methotrexate—esophageal cancer	0.000289	0.00315	CcSEcCtD
Zonisamide—Urine output increased—Methotrexate—esophageal cancer	0.000289	0.00315	CcSEcCtD
Zonisamide—Urinary tract disorder—Cisplatin—esophageal cancer	0.000289	0.00314	CcSEcCtD
Zonisamide—Liver function test abnormal—Capecitabine—esophageal cancer	0.000288	0.00313	CcSEcCtD
Zonisamide—Connective tissue disorder—Cisplatin—esophageal cancer	0.000288	0.00313	CcSEcCtD
Zonisamide—Urethral disorder—Cisplatin—esophageal cancer	0.000287	0.00312	CcSEcCtD
Zonisamide—Gynaecomastia—Methotrexate—esophageal cancer	0.000286	0.00311	CcSEcCtD
Zonisamide—Dry skin—Capecitabine—esophageal cancer	0.000286	0.00311	CcSEcCtD
Zonisamide—Hypokalaemia—Capecitabine—esophageal cancer	0.000284	0.00309	CcSEcCtD
Zonisamide—MAOB—lymph node—esophageal cancer	0.000281	0.00371	CbGeAlD
Zonisamide—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000281	0.00306	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000281	0.00306	CcSEcCtD
Zonisamide—Gastritis—Capecitabine—esophageal cancer	0.000276	0.003	CcSEcCtD
Zonisamide—Muscular weakness—Capecitabine—esophageal cancer	0.000275	0.00299	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000275	0.00299	CcSEcCtD
Zonisamide—Eye disorder—Cisplatin—esophageal cancer	0.000273	0.00298	CcSEcCtD
Zonisamide—Tinnitus—Cisplatin—esophageal cancer	0.000273	0.00297	CcSEcCtD
Zonisamide—Lymphadenopathy—Methotrexate—esophageal cancer	0.000272	0.00296	CcSEcCtD
Zonisamide—CA4—lymph node—esophageal cancer	0.000271	0.00357	CbGeAlD
Zonisamide—Dysphagia—Capecitabine—esophageal cancer	0.000269	0.00293	CcSEcCtD
Zonisamide—Influenza—Capecitabine—esophageal cancer	0.000269	0.00293	CcSEcCtD
Zonisamide—Thrombophlebitis—Methotrexate—esophageal cancer	0.000268	0.00292	CcSEcCtD
Zonisamide—Polyuria—Methotrexate—esophageal cancer	0.000264	0.00288	CcSEcCtD
Zonisamide—Immune system disorder—Cisplatin—esophageal cancer	0.000264	0.00288	CcSEcCtD
Zonisamide—Mediastinal disorder—Cisplatin—esophageal cancer	0.000264	0.00287	CcSEcCtD
Zonisamide—Alopecia—Cisplatin—esophageal cancer	0.000259	0.00281	CcSEcCtD
Zonisamide—Pancytopenia—Capecitabine—esophageal cancer	0.000256	0.00279	CcSEcCtD
Zonisamide—Malnutrition—Cisplatin—esophageal cancer	0.000255	0.00277	CcSEcCtD
Zonisamide—CYP3A4—digestive system—esophageal cancer	0.000253	0.00335	CbGeAlD
Zonisamide—Dysuria—Capecitabine—esophageal cancer	0.000252	0.00274	CcSEcCtD
Zonisamide—Flatulence—Cisplatin—esophageal cancer	0.000251	0.00273	CcSEcCtD
Zonisamide—Weight increased—Capecitabine—esophageal cancer	0.000245	0.00267	CcSEcCtD
Zonisamide—Muscle spasms—Cisplatin—esophageal cancer	0.000245	0.00267	CcSEcCtD
Zonisamide—Weight decreased—Capecitabine—esophageal cancer	0.000244	0.00265	CcSEcCtD
Zonisamide—Pneumonia—Capecitabine—esophageal cancer	0.000242	0.00263	CcSEcCtD
Zonisamide—MAOA—lymph node—esophageal cancer	0.00024	0.00316	CbGeAlD
Zonisamide—Depression—Capecitabine—esophageal cancer	0.00024	0.00261	CcSEcCtD
Zonisamide—Tremor—Cisplatin—esophageal cancer	0.000239	0.0026	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000238	0.00259	CcSEcCtD
Zonisamide—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000237	0.00258	CcSEcCtD
Zonisamide—Ill-defined disorder—Cisplatin—esophageal cancer	0.000236	0.00257	CcSEcCtD
Zonisamide—Renal failure—Capecitabine—esophageal cancer	0.000236	0.00257	CcSEcCtD
Zonisamide—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000236	0.00256	CcSEcCtD
Zonisamide—Anaemia—Cisplatin—esophageal cancer	0.000235	0.00256	CcSEcCtD
Zonisamide—Stomatitis—Capecitabine—esophageal cancer	0.000234	0.00255	CcSEcCtD
Zonisamide—Conjunctivitis—Capecitabine—esophageal cancer	0.000234	0.00254	CcSEcCtD
Zonisamide—Urinary tract infection—Capecitabine—esophageal cancer	0.000234	0.00254	CcSEcCtD
Zonisamide—Osteoarthritis—Methotrexate—esophageal cancer	0.000232	0.00253	CcSEcCtD
Zonisamide—Malaise—Cisplatin—esophageal cancer	0.00023	0.0025	CcSEcCtD
Zonisamide—Haematuria—Capecitabine—esophageal cancer	0.000229	0.00249	CcSEcCtD
Zonisamide—Leukopenia—Cisplatin—esophageal cancer	0.000228	0.00248	CcSEcCtD
Zonisamide—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000227	0.00247	CcSEcCtD
Zonisamide—CA2—lymph node—esophageal cancer	0.000224	0.00296	CbGeAlD
Zonisamide—Agranulocytosis—Capecitabine—esophageal cancer	0.000224	0.00244	CcSEcCtD
Zonisamide—Irritability—Methotrexate—esophageal cancer	0.000222	0.00241	CcSEcCtD
Zonisamide—Convulsion—Cisplatin—esophageal cancer	0.000221	0.0024	CcSEcCtD
Zonisamide—Mood swings—Methotrexate—esophageal cancer	0.00022	0.00239	CcSEcCtD
Zonisamide—Bradycardia—Capecitabine—esophageal cancer	0.00022	0.00239	CcSEcCtD
Zonisamide—Ataxia—Methotrexate—esophageal cancer	0.000218	0.00238	CcSEcCtD
Zonisamide—Myalgia—Cisplatin—esophageal cancer	0.000217	0.00236	CcSEcCtD
Zonisamide—Rhinitis—Capecitabine—esophageal cancer	0.000216	0.00235	CcSEcCtD
Zonisamide—Anxiety—Cisplatin—esophageal cancer	0.000216	0.00235	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000215	0.00234	CcSEcCtD
Zonisamide—Liver function test abnormal—Methotrexate—esophageal cancer	0.000214	0.00233	CcSEcCtD
Zonisamide—Discomfort—Cisplatin—esophageal cancer	0.000214	0.00233	CcSEcCtD
Zonisamide—Pharyngitis—Capecitabine—esophageal cancer	0.000214	0.00233	CcSEcCtD
Zonisamide—Urinary tract disorder—Capecitabine—esophageal cancer	0.000213	0.00232	CcSEcCtD
Zonisamide—Oedema peripheral—Capecitabine—esophageal cancer	0.000213	0.00231	CcSEcCtD
Zonisamide—Connective tissue disorder—Capecitabine—esophageal cancer	0.000212	0.00231	CcSEcCtD
Zonisamide—Urethral disorder—Capecitabine—esophageal cancer	0.000211	0.0023	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000209	0.00227	CcSEcCtD
Zonisamide—Oedema—Cisplatin—esophageal cancer	0.000208	0.00226	CcSEcCtD
Zonisamide—Infection—Cisplatin—esophageal cancer	0.000207	0.00225	CcSEcCtD
Zonisamide—Erythema multiforme—Capecitabine—esophageal cancer	0.000204	0.00222	CcSEcCtD
Zonisamide—Nervous system disorder—Cisplatin—esophageal cancer	0.000204	0.00222	CcSEcCtD
Zonisamide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000204	0.00222	CcSEcCtD
Zonisamide—Tachycardia—Cisplatin—esophageal cancer	0.000203	0.00221	CcSEcCtD
Zonisamide—Skin disorder—Cisplatin—esophageal cancer	0.000202	0.0022	CcSEcCtD
Zonisamide—Eye disorder—Capecitabine—esophageal cancer	0.000202	0.00219	CcSEcCtD
Zonisamide—Tinnitus—Capecitabine—esophageal cancer	0.000201	0.00219	CcSEcCtD
Zonisamide—Hyperhidrosis—Cisplatin—esophageal cancer	0.000201	0.00219	CcSEcCtD
Zonisamide—Eosinophilia—Methotrexate—esophageal cancer	0.000199	0.00216	CcSEcCtD
Zonisamide—Anorexia—Cisplatin—esophageal cancer	0.000198	0.00216	CcSEcCtD
Zonisamide—Pancreatitis—Methotrexate—esophageal cancer	0.000197	0.00214	CcSEcCtD
Zonisamide—Immune system disorder—Capecitabine—esophageal cancer	0.000195	0.00212	CcSEcCtD
Zonisamide—Mediastinal disorder—Capecitabine—esophageal cancer	0.000194	0.00212	CcSEcCtD
Zonisamide—Hypotension—Cisplatin—esophageal cancer	0.000194	0.00211	CcSEcCtD
Zonisamide—Alopecia—Capecitabine—esophageal cancer	0.000191	0.00207	CcSEcCtD
Zonisamide—Pancytopenia—Methotrexate—esophageal cancer	0.000191	0.00207	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000189	0.00206	CcSEcCtD
Zonisamide—Mental disorder—Capecitabine—esophageal cancer	0.000189	0.00206	CcSEcCtD
Zonisamide—Malnutrition—Capecitabine—esophageal cancer	0.000188	0.00204	CcSEcCtD
Zonisamide—Dysuria—Methotrexate—esophageal cancer	0.000188	0.00204	CcSEcCtD
Zonisamide—Paraesthesia—Cisplatin—esophageal cancer	0.000187	0.00203	CcSEcCtD
Zonisamide—Dyspnoea—Cisplatin—esophageal cancer	0.000185	0.00202	CcSEcCtD
Zonisamide—Flatulence—Capecitabine—esophageal cancer	0.000185	0.00201	CcSEcCtD
Zonisamide—Erectile dysfunction—Methotrexate—esophageal cancer	0.000185	0.00201	CcSEcCtD
Zonisamide—Dysgeusia—Capecitabine—esophageal cancer	0.000184	0.002	CcSEcCtD
Zonisamide—Decreased appetite—Cisplatin—esophageal cancer	0.000181	0.00197	CcSEcCtD
Zonisamide—Muscle spasms—Capecitabine—esophageal cancer	0.000181	0.00196	CcSEcCtD
Zonisamide—Pneumonia—Methotrexate—esophageal cancer	0.00018	0.00196	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000179	0.00195	CcSEcCtD
Zonisamide—Depression—Methotrexate—esophageal cancer	0.000178	0.00194	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000177	0.00193	CcSEcCtD
Zonisamide—Tremor—Capecitabine—esophageal cancer	0.000176	0.00191	CcSEcCtD
Zonisamide—Renal failure—Methotrexate—esophageal cancer	0.000176	0.00191	CcSEcCtD
Zonisamide—Stomatitis—Methotrexate—esophageal cancer	0.000174	0.0019	CcSEcCtD
Zonisamide—Ill-defined disorder—Capecitabine—esophageal cancer	0.000174	0.0019	CcSEcCtD
Zonisamide—Conjunctivitis—Methotrexate—esophageal cancer	0.000174	0.00189	CcSEcCtD
Zonisamide—Anaemia—Capecitabine—esophageal cancer	0.000174	0.00189	CcSEcCtD
Zonisamide—Sweating—Methotrexate—esophageal cancer	0.000171	0.00187	CcSEcCtD
Zonisamide—Feeling abnormal—Cisplatin—esophageal cancer	0.000171	0.00186	CcSEcCtD
Zonisamide—Haematuria—Methotrexate—esophageal cancer	0.000171	0.00186	CcSEcCtD
Zonisamide—Malaise—Capecitabine—esophageal cancer	0.000169	0.00184	CcSEcCtD
Zonisamide—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000169	0.00184	CcSEcCtD
Zonisamide—Vertigo—Capecitabine—esophageal cancer	0.000169	0.00184	CcSEcCtD
Zonisamide—Syncope—Capecitabine—esophageal cancer	0.000168	0.00183	CcSEcCtD
Zonisamide—Leukopenia—Capecitabine—esophageal cancer	0.000168	0.00183	CcSEcCtD
Zonisamide—Agranulocytosis—Methotrexate—esophageal cancer	0.000167	0.00182	CcSEcCtD
Zonisamide—Palpitations—Capecitabine—esophageal cancer	0.000166	0.00181	CcSEcCtD
Zonisamide—Loss of consciousness—Capecitabine—esophageal cancer	0.000165	0.0018	CcSEcCtD
Zonisamide—Body temperature increased—Cisplatin—esophageal cancer	0.000164	0.00179	CcSEcCtD
Zonisamide—Cough—Capecitabine—esophageal cancer	0.000164	0.00178	CcSEcCtD
Zonisamide—Hypertension—Capecitabine—esophageal cancer	0.000162	0.00176	CcSEcCtD
Zonisamide—Chest pain—Capecitabine—esophageal cancer	0.00016	0.00174	CcSEcCtD
Zonisamide—Myalgia—Capecitabine—esophageal cancer	0.00016	0.00174	CcSEcCtD
Zonisamide—Arthralgia—Capecitabine—esophageal cancer	0.00016	0.00174	CcSEcCtD
Zonisamide—Pharyngitis—Methotrexate—esophageal cancer	0.000159	0.00173	CcSEcCtD
Zonisamide—Anxiety—Capecitabine—esophageal cancer	0.000159	0.00173	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000159	0.00173	CcSEcCtD
Zonisamide—Urinary tract disorder—Methotrexate—esophageal cancer	0.000159	0.00173	CcSEcCtD
Zonisamide—Discomfort—Capecitabine—esophageal cancer	0.000158	0.00172	CcSEcCtD
Zonisamide—Urethral disorder—Methotrexate—esophageal cancer	0.000157	0.00171	CcSEcCtD
Zonisamide—Dry mouth—Capecitabine—esophageal cancer	0.000156	0.0017	CcSEcCtD
Zonisamide—Confusional state—Capecitabine—esophageal cancer	0.000155	0.00168	CcSEcCtD
Zonisamide—Oedema—Capecitabine—esophageal cancer	0.000153	0.00167	CcSEcCtD
Zonisamide—Hypersensitivity—Cisplatin—esophageal cancer	0.000153	0.00167	CcSEcCtD
Zonisamide—Infection—Capecitabine—esophageal cancer	0.000152	0.00166	CcSEcCtD
Zonisamide—Erythema multiforme—Methotrexate—esophageal cancer	0.000152	0.00165	CcSEcCtD
Zonisamide—Shock—Capecitabine—esophageal cancer	0.000151	0.00164	CcSEcCtD
Zonisamide—Nervous system disorder—Capecitabine—esophageal cancer	0.00015	0.00164	CcSEcCtD
Zonisamide—Eye disorder—Methotrexate—esophageal cancer	0.00015	0.00163	CcSEcCtD
Zonisamide—Thrombocytopenia—Capecitabine—esophageal cancer	0.00015	0.00163	CcSEcCtD
Zonisamide—Tinnitus—Methotrexate—esophageal cancer	0.00015	0.00163	CcSEcCtD
Zonisamide—Tachycardia—Capecitabine—esophageal cancer	0.00015	0.00163	CcSEcCtD
Zonisamide—Asthenia—Cisplatin—esophageal cancer	0.000149	0.00162	CcSEcCtD
Zonisamide—Skin disorder—Capecitabine—esophageal cancer	0.000149	0.00162	CcSEcCtD
Zonisamide—Hyperhidrosis—Capecitabine—esophageal cancer	0.000148	0.00161	CcSEcCtD
Zonisamide—Anorexia—Capecitabine—esophageal cancer	0.000146	0.00159	CcSEcCtD
Zonisamide—Immune system disorder—Methotrexate—esophageal cancer	0.000145	0.00158	CcSEcCtD
Zonisamide—Mediastinal disorder—Methotrexate—esophageal cancer	0.000145	0.00157	CcSEcCtD
Zonisamide—Hypotension—Capecitabine—esophageal cancer	0.000143	0.00156	CcSEcCtD
Zonisamide—Diarrhoea—Cisplatin—esophageal cancer	0.000142	0.00155	CcSEcCtD
Zonisamide—Alopecia—Methotrexate—esophageal cancer	0.000142	0.00154	CcSEcCtD
Zonisamide—Mental disorder—Methotrexate—esophageal cancer	0.000141	0.00153	CcSEcCtD
Zonisamide—Malnutrition—Methotrexate—esophageal cancer	0.00014	0.00152	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00014	0.00152	CcSEcCtD
Zonisamide—Insomnia—Capecitabine—esophageal cancer	0.000139	0.00151	CcSEcCtD
Zonisamide—Paraesthesia—Capecitabine—esophageal cancer	0.000138	0.0015	CcSEcCtD
Zonisamide—Dysgeusia—Methotrexate—esophageal cancer	0.000137	0.00149	CcSEcCtD
Zonisamide—Dyspnoea—Capecitabine—esophageal cancer	0.000137	0.00149	CcSEcCtD
Zonisamide—Dyspepsia—Capecitabine—esophageal cancer	0.000135	0.00147	CcSEcCtD
Zonisamide—Decreased appetite—Capecitabine—esophageal cancer	0.000133	0.00145	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000132	0.00144	CcSEcCtD
Zonisamide—Vomiting—Cisplatin—esophageal cancer	0.000132	0.00144	CcSEcCtD
Zonisamide—Fatigue—Capecitabine—esophageal cancer	0.000132	0.00144	CcSEcCtD
Zonisamide—Rash—Cisplatin—esophageal cancer	0.000131	0.00143	CcSEcCtD
Zonisamide—Constipation—Capecitabine—esophageal cancer	0.000131	0.00143	CcSEcCtD
Zonisamide—Dermatitis—Cisplatin—esophageal cancer	0.000131	0.00143	CcSEcCtD
Zonisamide—Ill-defined disorder—Methotrexate—esophageal cancer	0.00013	0.00141	CcSEcCtD
Zonisamide—Anaemia—Methotrexate—esophageal cancer	0.000129	0.00141	CcSEcCtD
Zonisamide—Feeling abnormal—Capecitabine—esophageal cancer	0.000126	0.00137	CcSEcCtD
Zonisamide—Malaise—Methotrexate—esophageal cancer	0.000126	0.00137	CcSEcCtD
Zonisamide—Vertigo—Methotrexate—esophageal cancer	0.000126	0.00137	CcSEcCtD
Zonisamide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000125	0.00136	CcSEcCtD
Zonisamide—Leukopenia—Methotrexate—esophageal cancer	0.000125	0.00136	CcSEcCtD
Zonisamide—Nausea—Cisplatin—esophageal cancer	0.000123	0.00134	CcSEcCtD
Zonisamide—Cough—Methotrexate—esophageal cancer	0.000122	0.00133	CcSEcCtD
Zonisamide—Urticaria—Capecitabine—esophageal cancer	0.000122	0.00132	CcSEcCtD
Zonisamide—Abdominal pain—Capecitabine—esophageal cancer	0.000121	0.00132	CcSEcCtD
Zonisamide—Body temperature increased—Capecitabine—esophageal cancer	0.000121	0.00132	CcSEcCtD
Zonisamide—Convulsion—Methotrexate—esophageal cancer	0.000121	0.00132	CcSEcCtD
Zonisamide—Chest pain—Methotrexate—esophageal cancer	0.000119	0.0013	CcSEcCtD
Zonisamide—Myalgia—Methotrexate—esophageal cancer	0.000119	0.0013	CcSEcCtD
Zonisamide—Arthralgia—Methotrexate—esophageal cancer	0.000119	0.0013	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000118	0.00129	CcSEcCtD
Zonisamide—Discomfort—Methotrexate—esophageal cancer	0.000118	0.00128	CcSEcCtD
Zonisamide—Confusional state—Methotrexate—esophageal cancer	0.000115	0.00125	CcSEcCtD
Zonisamide—Infection—Methotrexate—esophageal cancer	0.000113	0.00123	CcSEcCtD
Zonisamide—Hypersensitivity—Capecitabine—esophageal cancer	0.000113	0.00123	CcSEcCtD
Zonisamide—Nervous system disorder—Methotrexate—esophageal cancer	0.000112	0.00122	CcSEcCtD
Zonisamide—Thrombocytopenia—Methotrexate—esophageal cancer	0.000112	0.00122	CcSEcCtD
Zonisamide—Skin disorder—Methotrexate—esophageal cancer	0.000111	0.00121	CcSEcCtD
Zonisamide—Hyperhidrosis—Methotrexate—esophageal cancer	0.00011	0.0012	CcSEcCtD
Zonisamide—Asthenia—Capecitabine—esophageal cancer	0.00011	0.0012	CcSEcCtD
Zonisamide—Anorexia—Methotrexate—esophageal cancer	0.000109	0.00118	CcSEcCtD
Zonisamide—Pruritus—Capecitabine—esophageal cancer	0.000108	0.00118	CcSEcCtD
Zonisamide—Hypotension—Methotrexate—esophageal cancer	0.000107	0.00116	CcSEcCtD
Zonisamide—Diarrhoea—Capecitabine—esophageal cancer	0.000105	0.00114	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000104	0.00113	CcSEcCtD
Zonisamide—Insomnia—Methotrexate—esophageal cancer	0.000103	0.00112	CcSEcCtD
Zonisamide—Paraesthesia—Methotrexate—esophageal cancer	0.000102	0.00111	CcSEcCtD
Zonisamide—Dyspnoea—Methotrexate—esophageal cancer	0.000102	0.00111	CcSEcCtD
Zonisamide—Somnolence—Methotrexate—esophageal cancer	0.000101	0.0011	CcSEcCtD
Zonisamide—Dizziness—Capecitabine—esophageal cancer	0.000101	0.0011	CcSEcCtD
Zonisamide—Dyspepsia—Methotrexate—esophageal cancer	0.0001	0.00109	CcSEcCtD
Zonisamide—Decreased appetite—Methotrexate—esophageal cancer	9.92e-05	0.00108	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Methotrexate—esophageal cancer	9.85e-05	0.00107	CcSEcCtD
Zonisamide—Fatigue—Methotrexate—esophageal cancer	9.84e-05	0.00107	CcSEcCtD
Zonisamide—Vomiting—Capecitabine—esophageal cancer	9.74e-05	0.00106	CcSEcCtD
Zonisamide—Rash—Capecitabine—esophageal cancer	9.66e-05	0.00105	CcSEcCtD
Zonisamide—Dermatitis—Capecitabine—esophageal cancer	9.65e-05	0.00105	CcSEcCtD
Zonisamide—Headache—Capecitabine—esophageal cancer	9.6e-05	0.00104	CcSEcCtD
Zonisamide—Feeling abnormal—Methotrexate—esophageal cancer	9.4e-05	0.00102	CcSEcCtD
Zonisamide—Gastrointestinal pain—Methotrexate—esophageal cancer	9.33e-05	0.00102	CcSEcCtD
Zonisamide—Nausea—Capecitabine—esophageal cancer	9.1e-05	0.000991	CcSEcCtD
Zonisamide—Urticaria—Methotrexate—esophageal cancer	9.06e-05	0.000986	CcSEcCtD
Zonisamide—Body temperature increased—Methotrexate—esophageal cancer	9.02e-05	0.000981	CcSEcCtD
Zonisamide—Abdominal pain—Methotrexate—esophageal cancer	9.02e-05	0.000981	CcSEcCtD
Zonisamide—Hypersensitivity—Methotrexate—esophageal cancer	8.41e-05	0.000915	CcSEcCtD
Zonisamide—Asthenia—Methotrexate—esophageal cancer	8.19e-05	0.000891	CcSEcCtD
Zonisamide—Pruritus—Methotrexate—esophageal cancer	8.07e-05	0.000878	CcSEcCtD
Zonisamide—Diarrhoea—Methotrexate—esophageal cancer	7.81e-05	0.000849	CcSEcCtD
Zonisamide—Dizziness—Methotrexate—esophageal cancer	7.54e-05	0.000821	CcSEcCtD
Zonisamide—Vomiting—Methotrexate—esophageal cancer	7.25e-05	0.000789	CcSEcCtD
Zonisamide—Rash—Methotrexate—esophageal cancer	7.19e-05	0.000783	CcSEcCtD
Zonisamide—Dermatitis—Methotrexate—esophageal cancer	7.19e-05	0.000782	CcSEcCtD
Zonisamide—Headache—Methotrexate—esophageal cancer	7.15e-05	0.000778	CcSEcCtD
Zonisamide—Nausea—Methotrexate—esophageal cancer	6.78e-05	0.000737	CcSEcCtD
Zonisamide—AOX1—Metabolism—PTGS1—esophageal cancer	1.89e-05	0.000108	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MET—esophageal cancer	1.89e-05	0.000108	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	1.87e-05	0.000107	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PSME1—esophageal cancer	1.86e-05	0.000107	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PSME2—esophageal cancer	1.86e-05	0.000107	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PTGS2—esophageal cancer	1.85e-05	0.000106	CbGpPWpGaD
Zonisamide—CA12—Metabolism—ABCB1—esophageal cancer	1.84e-05	0.000106	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—EP300—esophageal cancer	1.83e-05	0.000105	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PLCE1—esophageal cancer	1.82e-05	0.000104	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ADH7—esophageal cancer	1.82e-05	0.000104	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—NOTCH1—esophageal cancer	1.81e-05	0.000104	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTT1—esophageal cancer	1.81e-05	0.000104	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—EP300—esophageal cancer	1.8e-05	0.000103	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ALDH2—esophageal cancer	1.79e-05	0.000103	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP2A6—esophageal cancer	1.78e-05	0.000102	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP1B1—esophageal cancer	1.78e-05	0.000102	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	1.78e-05	0.000102	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	1.76e-05	0.000101	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—EP300—esophageal cancer	1.72e-05	9.88e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CYP1B1—esophageal cancer	1.71e-05	9.8e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTT1—esophageal cancer	1.7e-05	9.77e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS1—esophageal cancer	1.69e-05	9.71e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ENO1—esophageal cancer	1.69e-05	9.71e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP2A6—esophageal cancer	1.68e-05	9.65e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP19A1—esophageal cancer	1.67e-05	9.61e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PSME2—esophageal cancer	1.67e-05	9.57e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PSME1—esophageal cancer	1.67e-05	9.57e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—TGFBR2—esophageal cancer	1.67e-05	9.57e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	1.67e-05	9.56e-05	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—EP300—esophageal cancer	1.65e-05	9.49e-05	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—EP300—esophageal cancer	1.65e-05	9.49e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—CREBBP—esophageal cancer	1.65e-05	9.45e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CYP1B1—esophageal cancer	1.64e-05	9.39e-05	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—EGFR—esophageal cancer	1.61e-05	9.25e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CYP1B1—esophageal cancer	1.6e-05	9.21e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CYP19A1—esophageal cancer	1.6e-05	9.21e-05	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—esophageal cancer	1.6e-05	9.19e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS1—esophageal cancer	1.59e-05	9.15e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ENO1—esophageal cancer	1.59e-05	9.15e-05	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—EP300—esophageal cancer	1.59e-05	9.15e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ADH1B—esophageal cancer	1.59e-05	9.15e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—SMAD4—esophageal cancer	1.58e-05	9.06e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PSME2—esophageal cancer	1.57e-05	9.02e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PSME1—esophageal cancer	1.57e-05	9.02e-05	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—EGFR—esophageal cancer	1.56e-05	8.96e-05	CbGpPWpGaD
Zonisamide—CA3—Metabolism—EP300—esophageal cancer	1.54e-05	8.84e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CYP19A1—esophageal cancer	1.54e-05	8.83e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	1.53e-05	8.81e-05	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—EGFR—esophageal cancer	1.53e-05	8.8e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—HMOX1—esophageal cancer	1.53e-05	8.77e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TYMP—esophageal cancer	1.52e-05	8.74e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CYP19A1—esophageal cancer	1.51e-05	8.66e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP26A1—esophageal cancer	1.48e-05	8.5e-05	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—EGFR—esophageal cancer	1.47e-05	8.42e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ABCB1—esophageal cancer	1.47e-05	8.41e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—HMOX1—esophageal cancer	1.46e-05	8.4e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—CREBBP—esophageal cancer	1.46e-05	8.37e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ALOX15—esophageal cancer	1.44e-05	8.29e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP1B1—esophageal cancer	1.44e-05	8.26e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CREBBP—esophageal cancer	1.42e-05	8.15e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—CREBBP—esophageal cancer	1.42e-05	8.15e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	1.42e-05	8.13e-05	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—EGFR—esophageal cancer	1.41e-05	8.09e-05	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—EGFR—esophageal cancer	1.41e-05	8.09e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ABCB1—esophageal cancer	1.41e-05	8.07e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—HMOX1—esophageal cancer	1.4e-05	8.06e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	1.4e-05	8.02e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—ERBB2—esophageal cancer	1.38e-05	7.91e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTO1—esophageal cancer	1.38e-05	7.9e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TPI1—esophageal cancer	1.38e-05	7.9e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—HMOX1—esophageal cancer	1.38e-05	7.9e-05	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—EGFR—esophageal cancer	1.36e-05	7.8e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP1B1—esophageal cancer	1.36e-05	7.78e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP19A1—esophageal cancer	1.35e-05	7.76e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ABCB1—esophageal cancer	1.35e-05	7.73e-05	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—EGFR—esophageal cancer	1.34e-05	7.68e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	1.34e-05	7.68e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	1.33e-05	7.64e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—CREBBP—esophageal cancer	1.33e-05	7.61e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CREBBP—esophageal cancer	1.33e-05	7.61e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ABCB1—esophageal cancer	1.32e-05	7.58e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ALDOB—esophageal cancer	1.32e-05	7.58e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	1.31e-05	7.54e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—NOS3—esophageal cancer	1.3e-05	7.49e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—HIF1A—esophageal cancer	1.29e-05	7.41e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP19A1—esophageal cancer	1.27e-05	7.32e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—NOS3—esophageal cancer	1.27e-05	7.3e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—NOS3—esophageal cancer	1.27e-05	7.3e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GAPDH—esophageal cancer	1.27e-05	7.29e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CRABP1—esophageal cancer	1.26e-05	7.23e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—HMOX1—esophageal cancer	1.23e-05	7.08e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CREBBP—esophageal cancer	1.23e-05	7.05e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GNG7—esophageal cancer	1.2e-05	6.88e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTGS2—esophageal cancer	1.19e-05	6.85e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—BLVRB—esophageal cancer	1.19e-05	6.83e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC52A3—esophageal cancer	1.19e-05	6.83e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—NOS3—esophageal cancer	1.19e-05	6.82e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—NOS3—esophageal cancer	1.19e-05	6.82e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ABCB1—esophageal cancer	1.18e-05	6.8e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—NOS2—esophageal cancer	1.17e-05	6.74e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—HMOX1—esophageal cancer	1.16e-05	6.68e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTGS2—esophageal cancer	1.16e-05	6.68e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTGS2—esophageal cancer	1.16e-05	6.68e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—NOTCH1—esophageal cancer	1.16e-05	6.68e-05	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PIK3CA—esophageal cancer	1.14e-05	6.54e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ALDH2—esophageal cancer	1.12e-05	6.44e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EP300—esophageal cancer	1.12e-05	6.43e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ABCB1—esophageal cancer	1.12e-05	6.41e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—NOS3—esophageal cancer	1.1e-05	6.31e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTGS2—esophageal cancer	1.09e-05	6.23e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTGS2—esophageal cancer	1.09e-05	6.23e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTT1—esophageal cancer	1.07e-05	6.13e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.06e-05	6.1e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP2A6—esophageal cancer	1.06e-05	6.06e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CREBBP—esophageal cancer	1.05e-05	6.05e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CA1—esophageal cancer	1.01e-05	5.81e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC10A2—esophageal cancer	1.01e-05	5.81e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTGS2—esophageal cancer	1.01e-05	5.77e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS1—esophageal cancer	1e-05	5.74e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ENO1—esophageal cancer	1e-05	5.74e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—EP300—esophageal cancer	9.93e-06	5.7e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PSME1—esophageal cancer	9.86e-06	5.66e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PSME2—esophageal cancer	9.86e-06	5.66e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CREBBP—esophageal cancer	9.8e-06	5.62e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—EP300—esophageal cancer	9.67e-06	5.55e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—EP300—esophageal cancer	9.67e-06	5.55e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EGFR—esophageal cancer	9.55e-06	5.48e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—NOS3—esophageal cancer	9.44e-06	5.42e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CREBBP—esophageal cancer	9.39e-06	5.39e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CA2—esophageal cancer	9.25e-06	5.31e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	9.04e-06	5.19e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—EP300—esophageal cancer	9.03e-06	5.18e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—EP300—esophageal cancer	9.03e-06	5.18e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CREBBP—esophageal cancer	9e-06	5.17e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CREBBP—esophageal cancer	8.83e-06	5.07e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—ERBB2—esophageal cancer	8.83e-06	5.07e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—NOS3—esophageal cancer	8.77e-06	5.04e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTGS2—esophageal cancer	8.63e-06	4.96e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PLCE1—esophageal cancer	8.6e-06	4.94e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ADH7—esophageal cancer	8.6e-06	4.94e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP1B1—esophageal cancer	8.51e-06	4.88e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	8.5e-06	4.88e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—NOS3—esophageal cancer	8.41e-06	4.83e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—EP300—esophageal cancer	8.37e-06	4.8e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—NOS3—esophageal cancer	8.06e-06	4.63e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTGS2—esophageal cancer	8.02e-06	4.61e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP19A1—esophageal cancer	8e-06	4.59e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CREBBP—esophageal cancer	7.92e-06	4.54e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—NOS3—esophageal cancer	7.91e-06	4.54e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—esophageal cancer	7.69e-06	4.42e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CDKN1A—esophageal cancer	7.55e-06	4.33e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ADH1B—esophageal cancer	7.54e-06	4.33e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CREBBP—esophageal cancer	7.46e-06	4.28e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—esophageal cancer	7.37e-06	4.23e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CA—esophageal cancer	7.34e-06	4.22e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—HMOX1—esophageal cancer	7.3e-06	4.19e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—esophageal cancer	7.23e-06	4.15e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TYMP—esophageal cancer	7.21e-06	4.14e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—EP300—esophageal cancer	7.18e-06	4.12e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CA—esophageal cancer	7.16e-06	4.11e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CA—esophageal cancer	7.16e-06	4.11e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	7.15e-06	4.11e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—BLVRB—esophageal cancer	7.15e-06	4.11e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—NOS3—esophageal cancer	7.09e-06	4.07e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP26A1—esophageal cancer	7.01e-06	4.02e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ABCB1—esophageal cancer	7e-06	4.02e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALOX15—esophageal cancer	6.83e-06	3.92e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CA—esophageal cancer	6.68e-06	3.84e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CA—esophageal cancer	6.68e-06	3.84e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NOS3—esophageal cancer	6.68e-06	3.83e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—EP300—esophageal cancer	6.67e-06	3.83e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTO1—esophageal cancer	6.52e-06	3.74e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TPI1—esophageal cancer	6.52e-06	3.74e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—esophageal cancer	6.48e-06	3.72e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—EP300—esophageal cancer	6.4e-06	3.67e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MYC—esophageal cancer	6.26e-06	3.59e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALDOB—esophageal cancer	6.25e-06	3.59e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CA—esophageal cancer	6.19e-06	3.55e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—EP300—esophageal cancer	6.13e-06	3.52e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—esophageal cancer	6.12e-06	3.51e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—esophageal cancer	6.11e-06	3.51e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CA1—esophageal cancer	6.08e-06	3.49e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	6.08e-06	3.49e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GAPDH—esophageal cancer	6.01e-06	3.45e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—EP300—esophageal cancer	6.01e-06	3.45e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CRABP1—esophageal cancer	5.96e-06	3.42e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GNG7—esophageal cancer	5.67e-06	3.25e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CA2—esophageal cancer	5.56e-06	3.19e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—EP300—esophageal cancer	5.39e-06	3.09e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALDH2—esophageal cancer	5.31e-06	3.05e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CA—esophageal cancer	5.31e-06	3.05e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PLCE1—esophageal cancer	5.17e-06	2.97e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ADH7—esophageal cancer	5.17e-06	2.97e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—EP300—esophageal cancer	5.08e-06	2.92e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTT1—esophageal cancer	5.05e-06	2.9e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP2A6—esophageal cancer	5e-06	2.87e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.98e-06	2.86e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CA—esophageal cancer	4.94e-06	2.83e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS1—esophageal cancer	4.74e-06	2.72e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ENO1—esophageal cancer	4.74e-06	2.72e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CA—esophageal cancer	4.73e-06	2.72e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CREBBP—esophageal cancer	4.68e-06	2.69e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PSME2—esophageal cancer	4.67e-06	2.68e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PSME1—esophageal cancer	4.67e-06	2.68e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CA—esophageal cancer	4.54e-06	2.6e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ADH1B—esophageal cancer	4.53e-06	2.6e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CA—esophageal cancer	4.45e-06	2.55e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TYMP—esophageal cancer	4.33e-06	2.49e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	4.22e-06	2.42e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NOS3—esophageal cancer	4.19e-06	2.41e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALOX15—esophageal cancer	4.11e-06	2.36e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.07e-06	2.34e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1B1—esophageal cancer	4.03e-06	2.31e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CA—esophageal cancer	3.99e-06	2.29e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TPI1—esophageal cancer	3.92e-06	2.25e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTO1—esophageal cancer	3.92e-06	2.25e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—esophageal cancer	3.83e-06	2.2e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP19A1—esophageal cancer	3.79e-06	2.17e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CA—esophageal cancer	3.76e-06	2.16e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.76e-06	2.16e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.62e-06	2.08e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.58e-06	2.06e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HMOX1—esophageal cancer	3.45e-06	1.98e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GNG7—esophageal cancer	3.41e-06	1.96e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.39e-06	1.95e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCB1—esophageal cancer	3.32e-06	1.9e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.19e-06	1.83e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—EP300—esophageal cancer	3.19e-06	1.83e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.04e-06	1.74e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3e-06	1.72e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ENO1—esophageal cancer	2.85e-06	1.63e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.85e-06	1.63e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PSME2—esophageal cancer	2.81e-06	1.61e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PSME1—esophageal cancer	2.81e-06	1.61e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.51e-06	1.44e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.42e-06	1.39e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CA—esophageal cancer	2.36e-06	1.35e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.28e-06	1.31e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CREBBP—esophageal cancer	2.22e-06	1.27e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.08e-06	1.19e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.99e-06	1.14e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NOS3—esophageal cancer	1.98e-06	1.14e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.81e-06	1.04e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—EP300—esophageal cancer	1.51e-06	8.66e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.33e-06	7.65e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NOS3—esophageal cancer	1.19e-06	6.85e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.12e-06	6.41e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.09e-06	6.26e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—EP300—esophageal cancer	9.08e-07	5.21e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	6.71e-07	3.85e-06	CbGpPWpGaD
